Keywords: OAC; Oral anticoagulant; VKA; Vitamin K antagonist; DOAC; Direct oral anticoagulant; PCC; Prothrombin complex concentrate; 4F-PCC; Four factor PCC; 3F-PCC; Three factor PCC; aPCC; Activated PCC; FFP; Fresh frozen plasma; AF; Atrial fibrillation; TE; Throm
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: EEC; endocardial endothelial cell; EPCR; endothelial protein C receptor; FIIa; thrombin; HF; heart failure; LVAD; left ventricular assist device; NGF; nerve growth factor; NPY; neuropeptide Y; TM; thrombomodulin; vWF; von Willebrand factor; Endocardial en
Capillary electrophoresis in the context of drug discovery
Keywords: ACE; affinity capillary electrophoresis; AGP; α-acid glycoprotein; AH; adrenaline hydrochloride; AIμEA; automatic micro-enzyme assay; AL; amlodipine; AT; antithrombin III; Bag3; Bcl2-associated anthanogene 3; BGE; background electrolyte; CM; chylomicron
Keywords: ADP; adenosine diphosphate; BSA; bovine serum albumin; CT; clotting time; ECL; enhanced chemiluminescence; FIIa; thrombin; FXIa; coagulation factor XIa; FITC; fluorescein isothiocyanate; HBS; Hepes-buffered saline; HSA; human serum albumin; IVIG; intraven
Structural analysis and biological activity of a highly regular glycosaminoglycan from Achatina fulica
Keywords: GAG; glycosaminoglycan; LMWH; low-molecular-weight heparin; DS; dermatan sulfate; TSP; trimethylsilyl-propionic acid; GlcA; glucuronic acid; GlcNAc; N-acetyl-2-deoxy-2-amino-glucose; IdoA; iduronic acid; IdoA2S; 2-sulfated iduronic acid; Mw; molecular wei
Interactions between depolymerized fucosylated glycosaminoglycan and coagulation proteases or inhibitors
Keywords: FG; fucosylated glycosaminoglycan; dFG; depolymerized fucosylated glycosaminoglycan; UFH; unfractionated heparin; LMWH; low molecular weight heparin; FXase; factor Xase; AT; antithrombin; FIIa; thrombin; FXa; factor Xa; FIXa; factor IXa; BLI; biolayer int
Sulfated low molecular weight lignins, allosteric inhibitors of coagulation proteinases via the heparin binding site, significantly alter the active site of thrombin and factor xa compared to heparin
Keywords: UFH; unfractionated heparin; LMWH; low molecular weight heparin; fIIa; factor IIa (thrombin); fXa; factor Xa; LMWL; low molecular weight lignin; Sulfated lignins; Heparin; Anticoagulation; Allosteric mechanism; Exosite II; Thrombin;
Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold
Keywords: Anticoagulant; Direct inhibition; Structure-activity relationships; Coagulation enzymes; Tetrahydroisoquinoline synthesis; ABH3CA; 2-azabicyclo[2.2.1]heptane-3-carboxylic acid; APTT; activated partial thromboplastin time; FIIa; factor IIa (thrombin); FX
Factor VIIa inhibitors: Gaining selectivity within the trypsin family
Keywords: Factor VIIa; Trypsin; Factor Xa; Thrombin; fIIa; Selectivity; Suzuki; Amidine; Lysine-192; Crystallography; Inhibitor
Flow injection immunoassay for carcinoembryonic antigen combined with time-resolved fluorometric detection
Keywords: BSA; Bovine serum albumin; CEA; Carcinoembryonic antigen; CV; Variation coefficient of variation; ECLIA; Electrochemiluminescence immunoassay; EIA; Enzyme immunoassay; FIA; Flow injection analysis; FIIA; Flow injection immunoassay; IRMA; Immunoradiometric